Short Interest in Mosaic ImmunoEngineering, Inc. (OTCMKTS:CPMV) Drops By 66.7%

Mosaic ImmunoEngineering, Inc. (OTCMKTS:CPMV) was the target of a large decline in short interest in the month of December. As of December 31st, there was short interest totalling 200 shares, a decline of 66.7% from the December 15th total of 600 shares. Based on an average daily trading volume, of 800 shares, the short-interest ratio is presently 0.3 days.

Mosaic ImmunoEngineering Price Performance

Mosaic ImmunoEngineering stock traded down $0.03 during midday trading on Tuesday, hitting $0.94. The company’s stock had a trading volume of 297 shares, compared to its average volume of 1,600. Mosaic ImmunoEngineering has a 1-year low of $0.10 and a 1-year high of $1.13. The company has a 50-day moving average price of $0.89 and a two-hundred day moving average price of $0.85. The company has a market cap of $6.81 million, a price-to-earnings ratio of -6.27 and a beta of 0.27.

About Mosaic ImmunoEngineering

Mosaic ImmunoEngineering, Inc, a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. Its lead immunotherapy product candidate, MIE-101, a nanoparticle-based treatment derived from cowpea mosaic virus, which is non-infectious in humans and animals.